Close

BTIG Boosts PT on bluebird bio (BLUE) to $83; Sees Favorable FDA Pathway Derisking Pivotal Study Timeline

Go back to BTIG Boosts PT on bluebird bio (BLUE) to $83; Sees Favorable FDA Pathway Derisking Pivotal Study Timeline